Advanced search
Start date
Betweenand
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Utrophin, MHC and M1/M2 macrophages in GRMD dogs

Full text
Author(s):
Gabriela Noronha de Toledo [1] ; Julieta Rodini Engracia de Moraes [2]
Total Authors: 2
Affiliation:
[1] Universidade Federal de Campina Grande. Centro de Saúde e Tecnologia Rural - Brasil
[2] Universidade Estadual de São Paulo "Julio de Mesquita Filho". Faculdade de Ciências Agrárias e Veterinárias. Departamento de Patologia Veterinária - Brasil
Total Affiliations: 2
Document type: Journal article
Source: Ciênc. anim. bras.; v. 21, 2020-08-19.
Abstract

Abstract Muscular dystrophies are hereditary diseases that lead to progressive degeneration of the skeletal musculature. Golden Retriever dogs are used as animal models because they show a hereditary muscle disease similar to muscular dystrophy in humans. Aims: To evaluate the immunostaining of M1 (CD68) and M2 (CD163) macrophages, MHC I, MHC II and, utrophin in muscles of Golden Retriever dogs affected by muscular dystrophy (GRMD). Methods: Samples from 17 male dogs affected by GRMD were divided into GI - dystrophic dogs up to one year of age; and GII - dystrophic dogs over one-year-old. Results: Immunostaining of CD163 was higher than CD68 in both GI and GII. CD68 showed no variation between groups of dystrophic animals. MHC class I immunostaining was most evident in the biceps femoris and triceps brachialis. MHC class II was expressed mildly in four dystrophic muscle types in GI and GII. Utrophin immunostaining was higher in GII. Conclusion: M2 macrophages were one of the main mononuclear inflammatory cells found in dystrophic muscles. The number of M2 in muscles of dogs with GRMD increases with age, linking this cell subtype to permanent muscle damage. (AU)

FAPESP's process: 11/07906-0 - Expression of utrophin, CD68 and CD163 in skeletal muscle of dogs affected by progressive muscular dystrophy
Grantee:Julieta Rodini Engracia de Moraes
Support Opportunities: Regular Research Grants